Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a revision update from v3.4.1 to v3.4.2, replacing the previous revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays Revision: v3.4.1 in the footer, replacing the previous v3.4.0, with no changes to the study details, eligibility criteria, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedA new Locations section appears, listing California, New York, Ohio, and Texas locations, and the page revision is updated to v3.3.3. The former state-specific location subsections have been removed.SummaryDifference0.5%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no study content or user actions are affected.SummaryDifference0.0%

- Check99 days agoChange DetectedThe funding-status disclaimer has been removed from the page. This may affect users’ expectations about whether the trial information is up to date.SummaryDifference0.3%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.